Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

No cure exists for alopecia areata, and treatments are personalized.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Pimpinella anisum L. extract significantly boosts hair growth in mice.

A rare scalp condition with hair loss was correctly diagnosed and treated, leading to hair regrowth.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Remove inflamed cysts surgically, avoid topical antibiotics on wounds, treat skin and mouth conditions with specific medications, and address underlying causes of hair loss.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Different nail disorders are treated by targeting their specific causes and using appropriate medications or protective measures.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The combination therapy effectively improved acne keloidalis nuchae.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Cholecystokinin may help reduce skin inflammation in psoriasis.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.